Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted therapy for social anxiety in autistic adults. “A MAPS-sponsored phase 2 pilot safety study of MDMA-assisted therapy for social anxiety in autistic adults showed strong and statistically significant improvements in social anxiety and functioning from short-term treatment with MDMA,” explains author Natan Ponieman.
Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?
Much like cannabis, psychedelics are catch…
